4-(2-METHOXYPHENYL)-2-PYRROLIDINONE, 97.0%, 250mg

5-Methoxy-1-methyl-1H-benzo[d]imidazol-2(3H)-one, 95.0%, 100mg

5-Hydroxybenzo[d]oxazol-2(3H)-one, 97.0%, 250mg

Ethyl-5-chloroindole-2-carboxylate, 98.0%, 25g

9-Azabicyclo[3.3.1]nonan-3-one, 95.0%, 250mg

N-(2-Bromo-4-nitrophenyl)acetamide, 95.0%, 2.5g

2-Chloro-3-(trifluoromethyl)isonicotinaldehyde, 97%, 1g

1-Pyridin-3-yl-ethylamine, 96.0%, 1g

3-Hydroxybenzaldehyde, min. 97%, for synthesis, 50 g, plastic packaging.

5-Bromoimidazo[1,5-a]pyridine, 95.0%, 5g

1-AMINO-5-CBZ-5-AZA-SPIRO[2.4]HEPTANE, 95.0%, 250mg

1-[(5-bromothiophen-2-yl)sulfonyl]piperazine (hydrochloride), 250mg

GC capillary column ROTI®Cap-1, 25 m, 0.20 mm, 0.20 µm, 1 Piece(s)